Serum metabolomic analysis of the anti-diabetic effect of Ginseng berry in type II diabetic rats based on ultra high-performance liquid chromatography-high resolution mass spectrometry

Heyu Wang,Rensong Huang,Hui Li,Lili Jiao,Shuying Liu,Wei Wu
DOI: https://doi.org/10.1016/j.jpba.2021.113897
IF: 3.571
2021-03-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:<p>Serum metabolomic method was used to investigated the anti-diabetic effects and mechanism of Ginseng berry (GB) on high-fat diet combined streptozotocin induced type II diabetes mellitus (T2DM) rats based on ultra high performance liquid chromatography coupled with quadrupole Exactive orbitrap mass spectrometry (UHPLC-Q-Exactive Orbitrap/MS). Serum samples from control group, T2DM group, metformin treatment group, and GB ginsenoside treatment group rats were collected after intervention. The biochemical parameters of serum were firstly analyzed. Then metabolomic studies based on UHPLC-Q-Exactive Orbitrap/MS and multivariate statistical analysis were performed for the pattern recognition and characteristic metabolites identification. The differential metabolites were analyzed by KEGG metabolic pathway to study the potential mechanism. The treatment of GB ginsenoside significantly reduced the blood glucose level, increased the content of serum SOD, and reduced the content of malondialdehyde. Respectively 16, 9, and 24 differential metabolites were found and identified in T2DM compared to control group, metformin compared to T2DM group and GB compared to T2DM group. Metabolic pathways analysis indicated that GB ginsenoside regulated bile acid metabolism, arachidonic acid metabolism, glucuronization to play a role in the treatment of T2DM. This study verified the anti-diabetic and anti-oxidation effects of ginseng berry, elaborated that GB regulated the secretion of bile acids, activated GLP-1 pathway, increased the secretion of insulin, promoted the hydrolysis of fat and triglyceride, inhibited the activity of 5α - reductase, reduced weight and insulin resistance, so as to improved and treated T2DM, and laid the foundation for the further development and utilization.</p>
pharmacology & pharmacy,chemistry, analytical
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the antidiabetic effect and mechanism of Ginseng berry (GB) on rats with type II diabetes mellitus (T2DM) induced by high - fat diet combined with streptozotocin (STZ). Specifically, through the serum metabolomics method, based on ultra - high - performance liquid chromatography - high - resolution mass spectrometry (UHPLC - Q - Exactive Orbitrap/MS), the study analyzed the metabolic effects of Ginseng berry on T2DM rats, aiming to discover the effects of Ginseng berry saponins on different metabolic pathways and the antidiabetic mechanism. ### Research Background and Objectives - **Background**: Ginseng (*Panax ginseng* C. A. Meyer) belongs to the Araliaceae family, and its main component, ginsenoside, has a variety of biological and pharmacological activities. The content of ginsenoside in Ginseng berry is 4 - 10 times higher than that in Ginseng root, especially the content of ginsenoside Re is almost 7 times that in Ginseng root. Although the research prospect of Ginseng berry is good, most studies are still focused on Ginseng root. - **Objectives**: Through the serum metabolomics method, to explore the antidiabetic effect and potential mechanism of Ginseng berry on T2DM rats, especially from the perspective of endogenous differential metabolites. ### Main Research Methods - **Animal Model**: Use the T2DM rat model induced by high - fat diet combined with STZ. - **Experimental Groups**: - Control group (CON): Normal diet, given normal saline. - T2DM group (DM): High - fat diet, given normal saline. - Metformin treatment group (MET): High - fat diet, given metformin at a dose of 100 mg/kg body weight. - Ginseng berry treatment group (GB): High - fat diet, given Ginseng berry extract at a dose of 200 mg/kg body weight. - **Detection Methods**: Serum metabolomics analysis was carried out by UHPLC - Q - Exactive Orbitrap/MS, combined with multivariate statistical analysis (PCA and OPLS - DA) to identify differential metabolites, and metabolic pathway analysis was carried out through the KEGG database. ### Main Results - **Antidiabetic Effect**: Ginseng berry significantly reduced the fasting blood - glucose level in T2DM rats, increased the content of superoxide dismutase (SOD) in serum, and decreased the content of malondialdehyde (MDA). - **Metabolomics Analysis**: 16, 9, and 24 differential metabolites were identified between the control group and the T2DM group, between the T2DM group and the metformin group, and between the T2DM group and the Ginseng berry group, respectively. - **Metabolic Pathway Analysis**: Ginseng berry saponins regulate metabolic pathways such as bile acid metabolism, arachidonic acid metabolism, and glucuronidation, thereby exerting an antidiabetic effect. ### Conclusion This study verified the antidiabetic and antioxidant effects of Ginseng berry, and elucidated that Ginseng berry improves and treats T2DM through mechanisms such as regulating bile acid secretion, activating the GLP - 1 pathway, increasing insulin secretion, promoting the hydrolysis of fat and triglyceride, inhibiting 5/H9251 - reductase activity, reducing body weight and insulin resistance. These findings lay the foundation for the further development and utilization of Ginseng berry.